|
EXP001233
|
Cell-penetrating peptides as transporters for morpholino oligomers: effects of …
|
2007 |
3c
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP001234
|
Cell-penetrating peptides as transporters for morpholino oligomers: effects of …
|
2007 |
3d
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP001235
|
Cell-penetrating peptides as transporters for morpholino oligomers: effects of …
|
2007 |
4a
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP001236
|
Cell-penetrating peptides as transporters for morpholino oligomers: effects of …
|
2007 |
4b
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP001237
|
Cell-penetrating peptides as transporters for morpholino oligomers: effects of …
|
2007 |
4c
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP001238
|
Delivery and tracking of quantum dot peptide bioconjugates in an intact develop…
|
2015 |
JB577 (QD-PEG-JB577 peptide–QD bioconjugate (DHLA-PEG coat; His6-ZnS coordination))
|
|
yes |
|
|
yes |
no |
|
EXP001239
|
Delivery and tracking of quantum dot peptide bioconjugates in an intact develop…
|
2015 |
JB577 (QD-CL4-JB577 peptide–QD bioconjugate (DHLA-CL4 coat; His6-ZnS coordination))
|
|
yes |
|
|
yes |
no |
|
EXP001240
|
Multifunctional siRNA Delivery System: Polyelectrolyte Complex Micelles of Six-…
|
2010 |
Hph1 + cl-KALA (self-crosslinked fusogenic KALA)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001241
|
Multifunctional siRNA Delivery System: Polyelectrolyte Complex Micelles of Six-…
|
2010 |
cl-KALA (self-crosslinked fusogenic KALA)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001242
|
Multifunctional siRNA Delivery System: Polyelectrolyte Complex Micelles of Six-…
|
2010 |
cl-KALA (self-crosslinked fusogenic KALA)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001243
|
Multifunctional siRNA Delivery System: Polyelectrolyte Complex Micelles of Six-…
|
2010 |
Hph1 + KALA (fusogenic peptide, non-crosslinked)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001250
|
Surfactant Protein B Promotes Cytosolic SiRNA Delivery by Adopting a Virus-like…
|
2021 |
KL4 (sinapultide)
|
siRNA
|
no |
no |
|
no |
no |
|
EXP001251
|
Reversal of ovarian cancer multidrug resistance by a combination of LAH4-L1-siM…
|
2018 |
LAH4-L1
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001252
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV1
|
PMO (antisense oligonucleotide)
|
yes |
yes |
|
no |
no |
|
EXP001253
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV2
|
PMO (antisense oligonucleotide)
|
yes |
yes |
|
no |
no |
|
EXP001254
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV1
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001255
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV1
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001256
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV1
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001257
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV1
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001258
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV1
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001259
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV2
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001260
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV2
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001261
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV2
|
PMO (antisense oligonucleotide)
|
no |
yes |
|
no |
no |
|
EXP001262
|
The endosomal escape vehicle platform enhances delivery of oligonucleotides in …
|
2023 |
EEV2
|
PMO (antisense oligonucleotide)
|
no |
yes |
|
no |
no |
|
EXP001263
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
Cyc(E4W5ACA) + SA-H8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001264
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
Cyc(E4W5ACA) + SA-R8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001265
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
SA-H8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001266
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
SA-R8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001267
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
Cyc(E4W5ACA) + SA-H8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001268
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
Cyc(E4W5ACA) + SA-H8
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP001269
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
Cyc(E4W5ACA) + SA-H8
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP001270
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
Cyc(E4W5ACA) + SA-R8
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP001271
|
Development of a multi-level pH-responsive lipid nanoplatform for efficient co-…
|
2024 |
SA-H8
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP001273
|
Cancer-Targeting Peptides Functionalized With Polyarginine Enables GRP78-Depend…
|
2025 |
R9
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001274
|
Cancer-Targeting Peptides Functionalized With Polyarginine Enables GRP78-Depend…
|
2025 |
W1-R9
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001275
|
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic…
|
2008 |
P007
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001276
|
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic…
|
2008 |
B peptide
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001277
|
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic…
|
2008 |
P007
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001278
|
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic…
|
2008 |
P007
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001279
|
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic…
|
2008 |
B peptide
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001280
|
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic…
|
2008 |
B peptide
|
PMO (antisense oligonucleotide)
|
no |
|
|
yes |
yes |
|
EXP001281
|
Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A…
|
2013 |
INF7-G4-R9-K
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001282
|
Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A…
|
2013 |
INF7-G4-R9-K
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001283
|
A gene delivery system for insect cells mediated by arginine-rich cell-penetrat…
|
2012 |
SR9 (R9)
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001284
|
A gene delivery system for insect cells mediated by arginine-rich cell-penetrat…
|
2012 |
HR9
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001285
|
A gene delivery system for insect cells mediated by arginine-rich cell-penetrat…
|
2012 |
PR9
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001286
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
9DR
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP001287
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
9LR
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP001288
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
RVG-9DR
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001289
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
RVG-9LR
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001290
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
scFvCD7-9DR
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001291
|
Attachment of Cell-Binding Ligands to Arginine-Rich Cell-Penetrating Peptides E…
|
2015 |
scFvCD7-9LR
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001292
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001293
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001294
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001295
|
The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene deli…
|
2016 |
Arg8
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001296
|
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid co…
|
2007 |
Tat
|
PNA (antisense)
|
yes |
yes |
|
no |
no |
|
EXP001297
|
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid co…
|
2007 |
Tat
|
PNA (antisense)
|
no |
yes |
|
no |
no |
|
EXP001298
|
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid co…
|
2007 |
Tat
|
PNA (antisense)
|
no |
no |
|
no |
no |
|
EXP001299
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(PR)20
|
ssRNA oligo
|
yes |
no |
|
no |
no |
|
EXP001300
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(GR)20
|
ssRNA oligo
|
yes |
no |
|
no |
no |
|
EXP001301
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(GA)20
|
ssRNA oligo
|
yes |
no |
|
no |
no |
|
EXP001302
|
Widespread displacement of DNA- and RNA-binding factors underlies toxicity of a…
|
2021 |
(PK)20
|
ssRNA oligo
|
yes |
no |
|
no |
no |
|
EXP001303
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001304
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
pDNA
|
no |
yes |
|
no |
no |
|
EXP001305
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001306
|
Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
|
2019 |
RL2 (recombinant lactaptin)
|
snoRNA (non-coding RNA)
|
no |
yes |
|
no |
no |
|
EXP001307
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
R8 (octaarginine)
|
PNA (antisense anti-miR)
|
yes |
yes |
|
no |
no |
|
EXP001308
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
secR8 (secondary amphipathic R8 variant)
|
PNA (antisense anti-miR)
|
yes |
no |
|
no |
no |
|
EXP001309
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
Pip6a (Pip CPP)
|
PNA (antisense anti-miR)
|
yes |
no |
|
no |
no |
|
EXP001310
|
Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid …
|
2021 |
K3 (trilysine)
|
PNA (antisense anti-miR)
|
yes |
no |
|
no |
no |
|
EXP001311
|
A novel cell-penetrating peptide to facilitate intercellular transport of fused…
|
2014 |
Tatm3x
|
|
yes |
|
|
no |
no |
|
EXP001312
|
A novel cell-penetrating peptide to facilitate intercellular transport of fused…
|
2014 |
Tat (basic domain)
|
|
yes |
|
|
no |
no |
|
EXP001313
|
A novel cell-penetrating peptide to facilitate intercellular transport of fused…
|
2014 |
Tatm
|
|
yes |
|
|
no |
no |
|
EXP001314
|
A novel cell-penetrating peptide to facilitate intercellular transport of fused…
|
2014 |
Tatm3x
|
|
no |
|
|
no |
no |
|
EXP001315
|
Application of Cell-Penetrating Peptides (CPP) to Enhance the Efficacy of Antis…
|
2025 |
TP10 (Transportan 10)
|
PNA (antisense; fluorescein-labeled) + NLS peptide tail
|
yes |
no |
|
no |
no |
|
EXP001316
|
Application of Cell-Penetrating Peptides (CPP) to Enhance the Efficacy of Antis…
|
2025 |
TP10 (Transportan 10)
|
PNA (antisense; fluorescein-labeled) + NLS peptide tail
|
yes |
no |
|
no |
no |
|
EXP001317
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep1
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP001318
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep2
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP001319
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep3
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001320
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
Ctrl
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP001321
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep3
|
siRNA
|
no |
yes |
yes |
no |
no |
|
EXP001322
|
Amphipathic Octenyl-Alanine Modified Peptides Mediate Effective siRNA Delivery
|
2025 |
hPep3
|
siRNA
|
no |
|
|
yes |
no |
|
EXP001323
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA (single-guide RNA)
|
no |
yes |
|
no |
no |
|
EXP001324
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA (single-guide RNA)
|
no |
yes |
|
no |
no |
|
EXP001325
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA (single-guide RNA)
|
no |
yes |
|
no |
no |
|
EXP001326
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA (single-guide RNA)
|
no |
yes |
|
no |
no |
|
EXP001327
|
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein a…
|
2014 |
9R (C3G9R4LC) + Cas9-m9R system
|
sgRNA (single-guide RNA)
|
no |
yes |
|
no |
no |
|
EXP001328
|
Cellular delivery of small interfering RNA by a non-covalently attached cell-pe…
|
2006 |
MPGα
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001329
|
Cellular delivery of small interfering RNA by a non-covalently attached cell-pe…
|
2006 |
MPGα-mNLS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001330
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
R6Pen–PNA705
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001331
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip1–PNA705
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001332
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2a–PNA705
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001333
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2b–PNA705
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001334
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
RXR4–PNA705
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001335
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip1–PNADMD
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001336
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2a–PNADMD
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001337
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip2b–PNADMD
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001338
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
RXR4–PNADMD
|
PNA (steric-blocking)
|
no |
yes |
|
no |
no |
|
EXP001339
|
Improved cell-penetrating peptide–PNA conjugates for splicing redirection in He…
|
2008 |
Pip1–PNADMD
|
PNA (steric-blocking)
|
no |
|
|
yes |
yes |